Chargement en cours...
Febuxostat in the management of hyperuricemia and chronic gout: a review
Febuxostat is a novel, potent, non-purine selective xanthine oxidase inhibitor, which in clinical trials demonstrated superior ability to lower and maintain serum urate levels below 6 mg/dL compared with conventionally used doses of allopurinol. Febuxostat was well tolerated in long term treatment i...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2643102/ https://ncbi.nlm.nih.gov/pubmed/19337428 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|